Patent · US Active

Piperidinone carboxamide azaindane CGRP receptor antagonists

US10272077B2 · kind B2 · utility

12Cited by

12References

19Claims

0Family size

Assignee

Merck Sharp & Dohme LLC · US

Inventors

Ian M. Bell · Harleysville, US
Mark E. Fraley · North Wales, US
Steven N. Gallicchio · Horsham, US
Anthony Ginetti · Perkasie, US
Helen J. Mitchell · Richboro, US
Daniel V. Paone · Lansdale, US
Donnette D. Staas · Harleysville, US
Cheng Wang · Fort Washington, US
C. Blair Zartman · Hatfield, US

Key dates

Filing date	Dec 4, 2017
Grant date	Apr 30, 2019
Priority date	—
Expiry date	Dec 4, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/20
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to piperidinone carboxamide azaindane derivatives which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.